The use of chromosomal microarray for prenatal diagnosis
- PMID: 27427470
- DOI: 10.1016/j.ajog.2016.07.016
The use of chromosomal microarray for prenatal diagnosis
Erratum in
-
October 2016 (vol. 215, no. 4, page B6).Am J Obstet Gynecol. 2017 Feb;216(2):180. doi: 10.1016/j.ajog.2016.11.1031. Epub 2016 Dec 7. Am J Obstet Gynecol. 2017. PMID: 27940137 No abstract available.
Abstract
Chromosomal microarray analysis is a high-resolution, whole-genome technique used to identify chromosomal abnormalities, including those detected by conventional cytogenetic techniques, as well as small submicroscopic deletions and duplications referred to as copy number variants. Because chromosomal microarray analysis has a greater resolution than conventional karyotyping, it can detect deletions and duplications down to a 50- to 100-kb level. The purpose of this document is to discuss the technique, advantages, and disadvantages of chromosomal microarray analysis and its indications and limitations. We recommend the following: (1) that chromosomal microarray analysis be offered when genetic analysis is performed in cases with fetal structural anomalies and/or stillbirth and replaces the need for fetal karyotype in these cases (GRADE 1A); (2) that providers discuss the benefits and limitations of chromosomal microarray analysis and conventional karyotype with patients who are considering amniocentesis and chorionic villus sampling (CVS), and that both options should be available to women who choose to undergo diagnostic testing (GRADE 1B); (3) that pre- and posttest counseling should be performed by trained genetic counselors, geneticists, or other providers with expertise in the complexities of interpreting chromosomal microarray analysis results (Best Practice); (4) that patients be informed that chromosomal microarray analysis does not detect every genetic disease or syndrome and specifically does not detect autosomal-recessive disorders associated with single gene point mutations, as well as that chromosomal microarray analysis can detect consanguinity and nonpaternity in some cases (Best Practice); (5) that patients in whom a fetal variant of uncertain significance is detected by prenatal diagnosis receive counseling from experts who have access to databases that provide updated information concerning genotype-phenotype correlations (Best Practice).
Keywords: chromosomal abnormalities; chromosomal microarray analysis; microarray; prenatal diagnosis.
Copyright © 2016. Published by Elsevier Inc.
Similar articles
-
Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis.Obstet Gynecol. 2013 Dec;122(6):1374-7. doi: 10.1097/01.AOG.0000438962.16108.d1. Obstet Gynecol. 2013. PMID: 24264715
-
Evaluation of prenatally diagnosed structural congenital anomalies.J Obstet Gynaecol Can. 2009 Sep;31(9):875-881. doi: 10.1016/S1701-2163(16)34307-9. J Obstet Gynaecol Can. 2009. PMID: 19941713 Review. English, French.
-
Dilemmas in genetic counseling for low-penetrance neuro-susceptibility loci detected on prenatal chromosomal microarray analysis.Am J Obstet Gynecol. 2018 Feb;218(2):247.e1-247.e12. doi: 10.1016/j.ajog.2017.11.559. Epub 2017 Nov 14. Am J Obstet Gynecol. 2018. PMID: 29146387
-
Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada.J Med Genet. 2018 Apr;55(4):215-221. doi: 10.1136/jmedgenet-2017-105013. Epub 2018 Mar 1. J Med Genet. 2018. PMID: 29496978 Free PMC article.
-
Chromosomal microarray analysis and prenatal diagnosis.Obstet Gynecol Surv. 2014 Oct;69(10):613-21. doi: 10.1097/OGX.0000000000000119. Obstet Gynecol Surv. 2014. PMID: 25336071 Review.
Cited by
-
How to choose a test for prenatal genetic diagnosis: a practical overview.Am J Obstet Gynecol. 2023 Feb;228(2):178-186. doi: 10.1016/j.ajog.2022.08.039. Epub 2022 Aug 24. Am J Obstet Gynecol. 2023. PMID: 36029833 Free PMC article.
-
Detection of copy number variants with chromosomal microarray in 10 377 pregnancies at a single laboratory.Acta Obstet Gynecol Scand. 2020 Jun;99(6):775-782. doi: 10.1111/aogs.13886. Epub 2020 May 17. Acta Obstet Gynecol Scand. 2020. PMID: 32346853 Free PMC article.
-
Prenatal genomic sequencing: Navigating uncertainty.Semin Perinatol. 2025 Apr;49(3):152058. doi: 10.1016/j.semperi.2025.152058. Epub 2025 May 21. Semin Perinatol. 2025. PMID: 40404237 Review.
-
The Role of MLPA in Detecting Syndromic Submicroscopic Copy Number Variations in Normal QF-PCR Miscarriage Specimens.Genes (Basel). 2025 Jul 24;16(8):867. doi: 10.3390/genes16080867. Genes (Basel). 2025. PMID: 40869914 Free PMC article.
-
Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells.Curr Obstet Gynecol Rep. 2019 Mar;8(1):1-8. Epub 2019 Jan 21. Curr Obstet Gynecol Rep. 2019. PMID: 31565541 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical